$75,65
▲ +$0,05
(+0,07%)
Vol. 3.1M
11
Punteggio di Qualità
ok
Analisi approfondita
1/5
fail
Ricavi ✗
Utile netto ✓
>IPO ✗
Cap. mercato
$16.6B
P/E
29,4
ROE
11,7%
Margine
13,8%
D/E
49,93
Beta
0,72
52W
$52–$75
Consenso Wall Street
23 analisti · Apr 20260
Acquisto forte
0
Compra
20
Mantieni
1
Vendi
2
Vendita forte
0,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $1,11 | $1,04 | $-0,07 |
| Set 2025 | $1,12 | $1,13 | +$0,01 |
| Giu 2025 | $1,07 | $1,08 | +$0,01 |
| Mar 2025 | $1,04 | $1,03 | $-0,01 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $1.0B | $1.0B | $1.0B | $1.0B | $1.0B |
| Utile netto | — | $201.0M | -$17.4M | $194.9M | $187.2M | $179.1M |
Trend fondamentali
| Metrica | 2025-06-28 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 11.5% | 11.5% | 11.5% | 11.5% | 11.7% | 11.7% |
| P/E (TTM) | 26.06 | 27.11 | 26.65 | 29.53 | 29.51 | 29.37 |
| Net Margin | 19.0% | 13.8% | 13.8% | 13.8% | 13.8% | 13.8% |
| Gross Margin | 56.3% | 56.3% | 56.3% | 56.3% | 56.1% | 56.4% |
| D/E Ratio | 52.09 | 52.09 | 52.09 | 52.09 | 49.68 | 49.93 |
| Current Ratio | 3.55 | 3.55 | 3.55 | 3.55 | 3.75 | 3.75 |
Rapporti chiave
ROA (TTM)
6,5%
P/S (TTM)
4,05
P/B
3,0
EPS (TTM)
$2,48
CF/Share
$3,14
Crescita ricavi 3A
-5,5%
52W High
$75,34
52W Low
$51,90
$51,90
Intervallo 52 settimane
$75,34
Salute finanziaria
Flusso di cassa libero
$194.8M
Debito netto
$352.3M
Liquidità
$2.2B
Debito totale
$2.5B
Aggiornato al Dic 31, 2025
Як HOLX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка HOLX vs аналоги Health Care
P/E
29,4
▼
4%
sotto
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
4,1
▲
57%
sopra
peer
(2,6)
vs Peer
vs Settore
Più costoso
P/B
3,0
▲
6%
sopra
peer
(2,8)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість HOLX vs аналоги Health Care
ROE
11,7%
▲
130%
sopra
peer
(-38,5%)
vs Peer
vs Settore
Top livello
Net margin
13,8%
▲
156%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Top livello
Валова маржа
56,4%
▲
7%
sopra
peer
(52,9%)
vs Peer
vs Settore
In linea
ROA
6,5%
▲
130%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя HOLX vs аналоги Health Care
D/E ratio
49,9
▲
159%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
3,8
▲
74%
sopra
peer
(2,2)
vs Peer
vs Settore
Liquidità forte
Beta
0,7
▼
31%
sotto
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів HOLX
HOLX
Mediana peer
Industria
HOLX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
HOLX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
DOCKENDORFF CHARLES J
Director · Feb 26
3190 shs
MCBRIDE-WENDELL AMY A.
Director · Feb 26
3190 shs
MADAUS MARTIN D PH.D.
Director · Feb 26
3190 shs
MCMILLAN WAYDE D
Director · Feb 26
3190 shs
STEWART STACEY D
Director · Feb 26
3190 shs
HANTSON LUDWIG N
Director · Feb 26
3190 shs
STAMOULIS CHRISTIANA
Director · Feb 26
3190 shs
MOHTASHAMI NANAZ
Director · Feb 26
3190 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 34,0%Vanguard Group Inc
11,69%
$2.0B
Blackrock Inc.
9,90%
$1.7B
State Street Corporation
4,42%
$746.1M
Manufacturers Life Insuranc…
4,23%
$713.3M
HBK Investments L P
3,76%
$634.6M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora